Annual Review 2025

Making the use of chemical substances safer for people and the environment. That is what Bureau REACH works on throughout the year. On behalf of the Netherlands we work in scope of the European REACH and CLP Regulations, which ensure the safe management of chemical substances in Europe.

This is our Annual Review 2025. In it, we look back on dossiers that stood out due to their specific challenges, complexity or societal relevance.

We hope you enjoy reading it!

  • The year 2025 did not bring the major changes we had expected: both the relocation of RIVM and the revision of REACH were postponed. Nevertheless, we continued…
  • In the past year, Bureau REACH finalised the Regulatory Management Options Analysis (RMOA) for the group of enzymes.
  • Bureau REACH makes an important contribution to the development of test methods. We do this in a European context and globally (OECD). Our main activities are…
  • Where there is concern about a substance, a restriction dossier can be prepared. This is a measure to limit exposure to the substance and remove unacceptable…
  • The RAC has adopted an opinion on the scientific evaluation of a limit value for 4,4’-isopropylidenediphenol (bisphenol A; BPA) and the screening of other…
  • In 2023, following the revision of the Regulation on Classification, Labelling and Packaging (CLP), new classification endpoints were introduced, including “…
  • A European strategy for the development and validation of test methods (EU Test Method Development & Validation Strategy) is an important policy priority…
  • Experts from Bureau REACH are actively involved in the expert group advising the European Commission on One Substance One Assessment (OSOA). 2025 proved to be…
  • The duration of evaluation and decision-making processes within the REACH work streams—substance evaluation, authorisation, restriction, and harmonised…
  • In this video, we present one of the follow-up steps after the RMOA process. One of the measures to manage concerns is the CLH process. Below, we illustrate…